Chronische Rückenschmerzen

Chronische Rückenschmerzen gehören zu den häufigsten Erkrankungen in Deutschland. Vielfach findet sich keine morphologisch fassbare Veränderung, sodass die Genese bei über 90% der Patienten unspezifisch bleibt. Der vorliegende Artikel soll eine Übersicht über die medikamentöse Therapie wie auch die nicht-medikamentösen Maßnahmen geben und fasst die entsprechenden Leitlinienempfehlungen zusammen.

Schlüsselwörter

chronischer lumbaler Rückenschmerz - Spondylarthritis - Spinalkanalstenose - Piriformissyndrom - multimodale Schmerztherapie

• Literatur

• 1 Balagué F, Mannion AF, Pellisé F. et al. Non-specific low back pain. Lancet 2012; 379: 482-491
• 2 Hoy D, March L, Brooks P. et al. The global burden of low back pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73: 968-974
• 3 Wenig CM, Schmidt CO, Kohlmann T. et al. Costs of back pain in Germany. Eur J Pain 2009; 13: 280-286
• 4 Dutmer AL, Schiphorst Preuper HR, Soer R. et al. Personal and societal impact of low back pain: the Groningen spine cohort. Spine 2019; 44: E1443-E1451
• 5 Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001; 344: 363-370
• 6 Foster NE, Anema JR, Cherkin D. et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018; 391: 2368-2383
• 7 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie nicht-spezifischer Kreuzschmerz – Langfassung. 2. Auflage. Version 1. 2017. Accessed October 27, 2022 at: https://www.leitlinien.de/themen/kreuzschmerz/2-auflage
• 8 de Schepper EI, Damen J, van Meurs JB. et al. The association between lumbar disc degeneration and low back pain: the influence of age, gender, and individual radiographic. Spine (Phila Pa 1976) 2010; 35: 531-536
• 9 Cheung KM, Karppinen J, Chan D. et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 2009; 34: 934-940
• 10 Endean A, Palmer KT, Coggon D. Potential of magnetic resonance imaging findings to refine case definition for mechanical low back pain in epidemiological studies: a systematic review. Spine (Phila Pa 1976) 2011; 36: 160-169
• 11 Hopayian K, Song F, Riera R. et al. The clinical features of the piriformis syndrome: a systematic review. Eur Spine J 2010; 19: 2095-2109
• 12 Park JW, Lee YK, Lee YJ. et al. Deep gluteal syndrome as a cause of posterior hip pain and sciatica-like pain. Bone Joint J 2020; 102-B: 556-567
• 13 Shiri R, Karppinen J, Leino-Arjas P. et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010; 171: 135-154
• 14 Shiri R, Karppinen J, Leino-Arjas P. et al. The association between smoking and low back pain: a meta-analysis. Am J Med 2010; 123: 87 e7-35
• 15 Kalichman L, Hunter DJ. The genetics of intervertebral disc degeneration. Familial predisposition and heritability estimation. Joint Bone Spine 2008; 75: 383-387
• 16 Roffey DM, Wai EK, Bishop P. et al. Causal assessment of occupational sitting and low back pain: results of a systematic review. Spine J 2010; 10: 252-261
• 17 Swain CTV, Pan F, Owen PJ. et al. No consensus on causality of spine postures or physical exposure and low back pain: a systematic review of systematic reviews. J Biomech 2020; 102: 109312
• 18 Jegan NR, Brugger M, Viniol A. et al. Psychological risk and protective factors for disability in chronic low back pain - a longitudinal analysis in primary care. BMC Musculoskelet Disord 2017; 18: 114
• 19 Nickel FT, Seifert F, Lanz S. et al. Mechanisms of neuropathic pain. Eur Neuropsychopharmacol 2012; 22: 81-91
• 20 Kobayashi Y, Kurata J, Sekiguchi M. et al. Augmented cerebral activation by lumbar mechanical stimulus in chronic low back pain patients: an FMRI study. Spine (Phila Pa 1976) 2009; 34: 2431-2436
• 21 Mayr A, Jahn P, Stankewitz A. et al. Patients with chronic pain exhibit individually unique cortical signatures of pain encoding. Hum Brain Mapp 2022; 43: 1676-1693
• 22 Chou R, Qaseem A, Snow V. et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147: 478-91
• 23 Wurmthaler C, Gerbershagen HU, Dietz G. et al. Chronifizierung und psychologische Merkmale-Die Beziehung zwischen Chronifizierungsstadien bei Schmerz und psychophysischem Befinden, Behinderung und familiären Merkmalen. Z Gesundheitspsych 1996; 4: 113-36
• 24 Laine L, Curtis SP, Cryer B. et al. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther 2010; 32: 1240-1248
• 25 Chang CH, Shau WY, Kuo CW. et al. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke 2010; 41: 1884-1890
• 26 Chaparro LE, Furlan AD, Deshpande A. et al. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev 2013; CD004959
• 27 Häuser W. 2. Aktualisierung der S3 Leitlinie „Langzeitanwendungen von Opioiden bei chronischen nicht-tumorbedingten Schmerzen „LONTS“. Schmerz 2020; 34: 204-244
• 28 Urquhart DM, Hoving JL, Assendelft WW. et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Re 2008; CD001703
• 29 Skljarevski V, Ossanna M, Liu-Seifert H. et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009; 16: 1041-1048
• 30 Mazza M, Mazza O, Pazzaglia C. et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother 2010; 11: 1049-52
• 31 Skljarevski V, Zhang S, Desaiah D. et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain 2010; 11: 1282-1290
• 32 Schukro RP, Oehmke MJ, Geroldinger A. et al. Efficacy of duloxetine in chronic low back pain with a neuropathic component: a randomized, double-blind, placebo-controlled crossover trial. Anesthesiology 2016; 124: 150-8
• 33 Romanò CL, Romanò D, Bonora C. et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol 2009; 10: 185-191
• 34 Freynhagen R, Baron R, Gockel U. et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-1920
• 35 Liddle SD, Gracey JH, Baxter GD. Advice for the management of low back pain: a systematic review of randomised controlled trials. Man Ther 2007; 12: 310-327
• 36 Sakai Y, Ito K, Hida T. et al. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration. Eur Spine J 2015; 24: 1309-17
• 37 Engers A, Jellema P, Wensing M. et al. Individual patient education for low back pain. Cochrane Database Syst Rev 2008; 1: CD004057